Again and Again, the FDA Fails American Patients

Source: Cato Institute
by Michael F Cannon

“Last week, the United Kingdom approved a new antiviral pill (molnupiravir). Studies show the drug reduces the risk of hospitalization and death among high‐​risk COVID patients by half. U.S. taxpayers funded molnupiravir’s development. Yet the U.S. Food and Drug Administration isn’t even meeting to consider approval until Nov. 30. Molnupiravir is the latest example of the FDA denying patients their most important health care right — the right to make their own health decisions — by prohibiting them from getting drugs that have received approval in other advanced countries.” (11/09/21)

https://www.cato.org/commentary/again-again-fda-fails-american-patients